Project Search Results

Select

Research Categorization

Operator
Operator

Project Details

Operator
Operator

Contact Researcher and Awardee Organization

Operator
Operator

Funding Organization

Operator
Operator
Operator
Operator
RELATED RESEARCH RESOURCES AND LINKS
ListGraphMap
Displaying 1 - 9 of 9 Projects
Project # Contact PI Funding Organization Fiscal Year
Validation of the human farnesyl pyrophosphate synthase (hFPPS) as a therapeutic target and design of pre-clinical candidates for the treatment of multiple myeloma and neurodegenerative diseases.
EUJPND-CIHR-Tsantrizos-487 TSANTRIZOS, Youla S Canadian Institutes of Health Research (CIHR) 2016
Structure-based design and discovery of improved anti-amyloidogenic compounds
EUJPND-CIHR-Wishart-494 Wishart, David S Canadian Institutes of Health Research (CIHR) 2016
The factor XII-driven contact system as a new therapeutic target in Alzheimer's disease
EUJPND-SF|ARS-Klohs-1594 Klohs, Jan Synapsis Foundation|Alzheimer Research Switzerland 2016
Validation of the human farnesyl pyrophosphate synthase (hFPPS) as a therapeutic target and design of pre-clinical candidates for the treatment of multiple myeloma and neurodegenerative diseases.
CIHR-TSANTRIZOS-2014 TSANTRIZOS, Youla S Canadian Institutes of Health Research (CIHR) 2014
Structure-based design and discovery of improved anti-amyloidogenic compounds
CIHR-WISHART-2014 WISHART, David Scott Canadian Institutes of Health Research (CIHR) 2014
Validation of the human farnesyl pyrophosphate synthase (hFPPS) as a therapeutic target and design of pre-clinical candidates for the treatment of multiple myeloma and neurodegenerative diseases.
CIHR-TSANTRIZOS-2013 TSANTRIZOS, Youla S Canadian Institutes of Health Research (CIHR) 2013
Structure-based design and discovery of improved anti-amyloidogenic compounds
CIHR-WISHART-2013 WISHART, David Scott Canadian Institutes of Health Research (CIHR) 2013
Validation of the human farnesyl pyrophosphate synthase (hFPPS) as a therapeutic target and design of pre-clinical candidates for the treatment of multiple myeloma and neurodegenerative diseases.
CIHR-TSANTRIZOS-2012 TSANTRIZOS, Youla S Canadian Institutes of Health Research (CIHR) 2012
Structure-based design and discovery of improved anti-amyloidogenic compounds
CIHR-WISHART-2012 WISHART, David Scott Canadian Institutes of Health Research (CIHR) 2012